Responses

This article has a correction. Please see:

Download PDFPDF

A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Justification for complete revascularisation at the time of primary angioplasty? Not yet!
    • Nick West
    • Other Contributors:
      • Francis R. Joshi, Liam McCormick

    We read with great interest the article by Politi et al. (1) on revascularisation of patients presenting with ST-elevation myocardial infarction (STEMI) in the context of multivessel coronary disease, and its accompanying Editorial. Whilst the data are interesting and hypothesis- generating, they fall short of demanding any change in current practice owing to a potential flaw in the study design and in the findings as pre...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    is it reasonable to separate the culprit-vessel only revascularization as a group from the culprit-vessel revascularization?

    We read with interest the work "A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up"by Luigi Politi. According to the conclusion of the article, culprit vessel- only angioplasty was associated with the highest rate of long-term MACE compared with multivessel treatment including simultaneous revascularizati...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    To the Editor

    With great interest we have read the article by Politi et al(1) on revascularisation of patients with ST-elevation myocardial infarction and multivessel disease. The authors are to be complimented with the largest randomised trial on this subject, with the longest follow-up.

    However, we question whether this study is the 'justification for complete revascularisation at the time of primary angioplasty', as the p...

    Show More
    Conflict of Interest:
    None declared.